Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07015112

Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)

The goal of this clinical trial is to learn if a multi-professional (conducted by geriatricians, clinical pharmacists, nurses) medication revision, centered on patients' goals and characteristics, can improve treatment adequacy in older adults admitted to an intermediate care hospital.

The main question it aims to answer is: does this approach reduce the average number of medications taken per patient?

Researchers will compare this multi-professional patient-centered revision to the usual standard of care (treatment revision conducted by a clinical pharmacist) to see if the patient-centered revision works in improving treatment adequacy.

Participants admitted to an intermediate care hospital will undergo a comprehensive assessment by a geriatrician, and a medication revision (conducted by a multidisciplinary team or a clinical-pharmacist alone). They will also be asked to fulfill some questionnaires on their health status and attitudes. Any possible adverse events to the medications will be recorded at discharge. Participants will be contacted again three months after discharge to check for any readmission or death.

Recruiting

Interested in participating?

Request Info

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Parc Sanitari Pere Virgili

Barcelona, 08023, Spain

Location status: Recruiting

Location contact

Ana M de Andrés Lázaro, Pharmacist, PhD

CONTACT

[email protected]

+34 93 259 41 28

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • older adults (65+ years)
  • ≥ 3 or more chronic conditions requiring medical therapy
  • able to speak Spanish
  • capacity to provide informed consent or have a surrogate able to consent on their behalf

Exclusion criteria

  • unable to provide informed consent
  • anticipated length of hospital stay < 72h
  • estimated life expectancy < 3 months
  • homeless
  • already enrolled in a drug trial

Treatment and study plan

Patient-centered multidisciplinary treatment review

Other

Patient-centered multidisciplinary treatment review is defined as a medication review conducted by a multidisciplinary team (geriatrician, clinical pharmacist, nurse) according to a patient-centered methodology, based on person-centered evaluation of both personal and clinical insights, diagnostic-centered evaluation (based on current guidelines), and drug-centered evaluation (based on adequacy)

Primary outcomes

  1. Number of drugs

    Time frame: Baseline and after discharge, an average of 30 days

    Median number of drugs per patient

Study contacts

Contact information is provided by the study sponsor or research team.

Ana M de Andrés Lázaro, Pharmacist. PhD

CONTACT

[email protected]

+34932594128

Sponsors and collaborators

Lead sponsor

Parc Sanitari Pere Virgili

Other

Registry information

Official study title

Applying a Multidisciplinary Intervention for Drug Adequacy in a Intermediate Care Hospital (AMIDA-ICH)

Acronym: AMIDA-ICH

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Jun 11, 2025
Registry last updated
Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.